NextCure, Inc. (NXTC)
NASDAQ·Healthcare·Biotechnology
$9.50
-1.30%
Mkt Cap $33.52M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | — | — | — | -$2.26 | -$0.81 | +64.16% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$4.06 | -$3.22 | +20.69% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$4.62 | -$11.29 | -144.37% | — | — |
| Q2 2025 May 1, 2025 | — | — | — | -$4.80 | -$4.68 | +2.50% | — | — |
| Q1 2025 Mar 6, 2025 | — | — | — | -$4.08 | -$4.92 | -20.59% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$4.20 | -$4.92 | -17.14% | — | — |
| Q3 2024 Aug 1, 2024 | — | — | — | -$4.32 | -$6.60 | -52.78% | — | — |
| Q2 2024 May 2, 2024 | — | — | — | -$5.40 | -$7.32 | -35.56% | — | — |
| Q1 2024 Mar 21, 2024 | — | — | — | -$6.48 | -$6.24 | +3.70% | — | — |
| Q4 2023 Nov 2, 2023 | — | — | — | -$7.68 | -$6.12 | +20.31% | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | -$7.20 | -$7.68 | -6.67% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$7.68 | -$6.96 | +9.37% | — | — |
| Q1 2023 Mar 2, 2023 | — | — | — | -$7.80 | -$7.44 | +4.62% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$7.20 | -$8.16 | -13.33% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$8.76 | -$7.80 | +10.96% | — | — |
| Q2 2022 May 5, 2022 | — | — | — | -$8.16 | -$8.88 | -8.82% | — | — |
| Q1 2022 Mar 3, 2022 | — | — | — | -$8.04 | -$7.32 | +8.96% | — | — |
| Q4 2021 Nov 4, 2021 | — | — | — | -$8.04 | -$7.80 | +2.99% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$7.20 | -$7.80 | -8.33% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$6.84 | -$7.20 | -5.26% | — | — |